STOCK TITAN

PolyPid to Participate in Citizens JMP Life Sciences Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PolyPid (Nasdaq: PYPD) will participate in the Citizens JMP Life Sciences Conference in New York to present their late-stage biopharma innovations aimed at enhancing surgical outcomes. The event will be held from May 13 – 14, 2024, with a management presentation scheduled for May 13 at 2:30 PM ET.

PolyPid (Nasdaq: PYPD) parteciperà alla Citizens JMP Life Sciences Conference a New York per presentare le sue innovazioni biopharmaceutiche in fase avanzata, volte a migliorare i risultati degli interventi chirurgici. L'evento si terrà dal 13 al 14 maggio 2024, con una presentazione della direzione prevista per il 13 maggio alle 14:30 ET.
PolyPid (Nasdaq: PYPD) participará en la conferencia Citizens JMP Life Sciences en Nueva York para presentar sus innovaciones biofarmacéuticas en etapas avanzadas destinadas a mejorar los resultados quirúrgicos. El evento se llevará a cabo del 13 al 14 de mayo de 2024, con una presentación de la gestión programada para el 13 de mayo a las 2:30 PM ET.
폴리피드(PolyPid, 나스닥: PYPD)는 뉴욕의 시티즌스 JMP 라이프 사이언스 컨퍼런스에 참가하여 수술 결과를 향상시키기 위한 후기 단계의 바이오 제약 혁신을 발표할 예정입니다. 이 행사는 2024년 5월 13일부터 14일까지 열리며, 경영진 발표는 5월 13일 오후 2시 30분 ET에 예정되어 있습니다.
PolyPid (Nasdaq: PYPD) participera à la conférence Citizens JMP Life Sciences à New York pour présenter ses innovations biopharmaceutiques de dernière étape visant à améliorer les résultats chirurgicaux. L'événement se tiendra du 13 au 14 mai 2024, avec une présentation de la gestion prévue le 13 mai à 14h30 ET.
PolyPid (Nasdaq: PYPD) wird an der Citizens JMP Life Sciences Konferenz in New York teilnehmen, um ihre biopharmazeutischen Innovationen in einem späten Entwicklungsstadium vorzustellen, die darauf abzielen, chirurgische Ergebnisse zu verbessern. Die Veranstaltung findet vom 13. bis 14. Mai 2024 statt, eine Präsentation des Managements ist für den 13. Mai um 14:30 Uhr ET geplant.
Positive
  • None.
Negative
  • None.

PETACH TIKVA, Israel, May 01, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that company management will present at the Citizens JMP Life Sciences Conference taking place in New York, NY, from May 13 – 14, 2024.

Citizens JMP Life Sciences Conference Presentation
Date: Monday, May 13, 2024
Time:2:30 PM ET
  

The PolyPid management team will participate in one-on-one investor meetings during this event. Investors interested in meeting with PolyPid around the conference should contact their Citizens JMP representative.

About PolyPid

PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.

For additional Company information, please visit http://www.polypid.com and follow us on Twitter and LinkedIn.

Contacts:
PolyPid Ltd. 
Ori Warshavsky
COO – US
908-858-5995
IR@Polypid.com

Investors:
Brian Ritchie
LifeSci Advisors
212-915-2578
britchie@lifesciadvisors.com


FAQ

When and where will PolyPid participate in the Citizens JMP Life Sciences Conference?

PolyPid will participate in the Citizens JMP Life Sciences Conference in New York from May 13 – 14, 2024, with a management presentation scheduled for May 13 at 2:30 PM ET.

What is the stock symbol of PolyPid?

PolyPid's stock symbol is PYPD.

How can investors arrange meetings with PolyPid during the conference?

Investors interested in meeting with PolyPid around the conference should contact their Citizens JMP representative.

PolyPid Ltd. Ordinary Shares

NASDAQ:PYPD

PYPD Rankings

PYPD Latest News

PYPD Stock Data

22.93M
4.80M
20.52%
32.01%
0.09%
Biotechnology
Healthcare
Link
United States of America
Petah Tikva